Free Trial

AIM ImmunoTech (AIM) Short Interest Ratio & Short Volume

AIM ImmunoTech logo
$0.09 -0.03 (-22.34%)
As of 04/4/2025
This is a fair market value price provided by Polygon.io. Learn more.

AIM ImmunoTech Short Interest Data

AIM ImmunoTech (AIM) has a short interest of 3.17 million shares. This marks a -3.65% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.1, indicating that it would take 3.1 days of the average trading volume of 579,401 shares to cover all short positions.

Current Short Interest
3,170,000 shares
Previous Short Interest
3,290,000 shares
Change Vs. Previous Month
-3.65%
Dollar Volume Sold Short
$367,720.00
Short Interest Ratio
3.1 Days to Cover
Last Record Date
March 14, 2025
Outstanding Shares
72,290,000 shares
Percentage of Shares Shorted
4.39%
Today's Trading Volume
2,305,517 shares
Average Trading Volume
579,401 shares
Today's Volume Vs. Average
398%
Short Selling AIM ImmunoTech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AIM ImmunoTech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AIM Short Interest Over Time

AIM Days to Cover Over Time

AIM Percentage of Float Shorted Over Time

AIM ImmunoTech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/14/20253,170,000 shares $367,720.00 -3.7%N/A3.1 $0.12
2/28/20253,290,000 shares $444,150.00 -3.5%N/A3.2 $0.14
2/14/20253,410,000 shares $439,890.00 +272.8%N/A3.5 $0.13
1/31/2025914,800 shares $184,698.12 +44.7%N/A1 $0.20
1/15/2025632,200 shares $119,865.12 +22.6%N/A1 $0.19

AIM Short Interest - Frequently Asked Questions

What is AIM ImmunoTech's current short interest?

Short interest is the volume of AIM ImmunoTech shares that have been sold short but have not yet been covered or closed out. As of March 14th, investors have sold 3,170,000 shares of AIM short. Learn More on AIM ImmunoTech's current short interest.

What is a good short interest ratio for AIM ImmunoTech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AIM shares currently have a short interest ratio of 3.0. Learn More on AIM ImmunoTech's short interest ratio.

Is AIM ImmunoTech's short interest increasing or decreasing?

AIM ImmunoTech saw a drop in short interest during the month of March. As of March 14th, there was short interest totaling 3,170,000 shares, a drop of 3.6% from the previous total of 3,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does AIM ImmunoTech's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AIM ImmunoTech: ImmunoPrecise Antibodies Ltd. (0.76%), Eagle Pharmaceuticals, Inc. (0.42%), Generation Bio Co. (4.12%), CytoMed Therapeutics Limited (1.40%), Cyclacel Pharmaceuticals, Inc. (0.29%), Tenax Therapeutics, Inc. (8.55%), NanoViricides, Inc. (0.44%), Tempest Therapeutics, Inc. (3.80%), Cara Therapeutics, Inc. (1.74%), CalciMedica, Inc. (2.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Domino's Pizza, Inc. ($736.25 million), The Campbell's Company ($649.30 million), Science Applications International Co. ($285.09 million), Brookfield Infrastructure Co. ($244.13 million), Renasant Co. ($199.30 million), Dream Finders Homes, Inc. ($153.47 million), Xerox Holdings Co. ($145.39 million), First Advantage Co. ($78.80 million), Zymeworks Inc. ($66.40 million), and Kforce Inc. ($53.83 million). View all of the most shorted stocks.

What does it mean to sell short AIM ImmunoTech stock?

Short selling AIM is an investing strategy that aims to generate trading profit from AIM ImmunoTech as its price is falling. AIM shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AIM ImmunoTech?

A short squeeze for AIM ImmunoTech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AIM, which in turn drives the price of the stock up even further.

How often is AIM ImmunoTech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AIM, twice per month. The most recent reporting period available is March, 14 2025.




This page (NYSE:AIM) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners